![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 16, 2020 7:13:14 AM
6:29 am ET October 16, 2020 (Dow Jones) Print
By Chris Wack
Orchard Therapeutics Plc said Friday the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending full, or standard, marketing authorization for Libmeldy, an investigational gene therapy for the treatment of metachromatic leukodystrophy.
The company said the CHMP's positive opinion will now be reviewed by the European Commission, which has the authority to grant marketing authorization for Libmeldy in the European Union.
A final decision by the EC for Libmeldy is anticipated before the end of 2020. If approved, Libmeldy would be the first commercial therapy and first gene therapy for eligible patients with early-onset MLD.
MLD is a severe genetic condition caused by mutations in the ARSA gene which lead to neurological damage and developmental regression.
Libmeldy is designed as a one-time gene therapy. The positive CHMP opinion is supported by clinical studies of Libmeldy in both pre- and early- symptomatic, early-onset MLD patients. Clinical efficacy was based on the integrated analysis of results from 29 patients with early-onset MLD who were all treated with Libmeldy prepared as a fresh formulation.
Recent ORTX News
- Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024 • GlobeNewswire Inc. • 05/07/2024 11:00:17 AM
- Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List • GlobeNewswire Inc. • 05/03/2024 11:00:38 AM
- Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy • GlobeNewswire Inc. • 03/20/2024 11:00:07 AM
- Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S. • GlobeNewswire Inc. • 03/18/2024 07:41:13 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/15/2024 02:05:44 AM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/05/2024 07:39:49 PM
- Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome • GlobeNewswire Inc. • 02/05/2024 12:00:03 PM
- Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium • GlobeNewswire Inc. • 02/02/2024 12:00:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/31/2024 05:15:12 AM
- Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy • GlobeNewswire Inc. • 01/25/2024 12:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:20:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:18:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:17:53 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 01/24/2024 09:41:53 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/24/2024 09:28:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:17:00 PM
- Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases • GlobeNewswire Inc. • 01/24/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:10:55 PM
FEATURED Element79 Gold Corp Provides Update on Nevada Portfolio • Aug 23, 2024 8:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM